← Evidence map

ArticleCureus2025

Clinical Outcomes of Anorganic Bone Matrix Combined With a P-15 Osteogenic Cell-Binding Peptide (ABM/P-15) in One- and Two-Level Transforaminal Lumbar Interbody Fusion (TLIF): A Propensity-Matched Comparison.

Mitsuhiro Nishizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Clinical Outcomes of Anorganic Bone Matrix Combined With a P-15 Osteogenic Cell-Binding Peptide (ABM/P-15) in One- and Two-Level Transforaminal Lumbar Interbody Fusion (TLIF): A Propensity-Matched Comparison. | OpenQuestion